Answers are grounded in this paper and cite their sources.
Adjuvant anti-PD-1/PD-L1 treatment is associated with an increased RFS in the overall population and in subgroups divided according to age and gender.
No takes yet. Share an insight, caveat, or question.
Rizzo et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: